{
  "abstract": "The unprecedented speed of clinical trial set up and execution in response to the covid-19 pandemic was only possible because of long established and experienced clinical trial capacity in almost exclusively high income settings such as the US and Europe. As a result, data from many global populations could not be accommodated in time for emergency use authorisation and the subsequent large scale deployment of vaccines that ultimately resulted in the safe end to the pandemic. The key lesson is the need to strengthen and sustain clinical trial capacity in sub-Saharan Africa to the level of demand experienced in 2020.",
  "authors": [
    {
      "affiliations": [
        "School of Chemical Engineering, University of Birmingham, Birmingham, UK",
        "Department of Infectious Diseases & Tropical Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, Birmingham, UK"
      ],
      "name": "Alice E Taylor"
    },
    {
      "affiliations": [
        "University of Birmingham College of Medical and Dental Sciences, Birmingham, Birmingham, UK"
      ],
      "name": "Gabriella Millard"
    },
    {
      "affiliations": [
        "School of Chemical Engineering, University of Birmingham, Birmingham, UK",
        "Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK"
      ],
      "name": "Alice Packham"
    },
    {
      "affiliations": [
        "Rwanda Biomedical Center, Kigali, Rwanda",
        "Research, Innovation and Data Science Division, Rwanda Biomedical Center, Kigali, Rwanda"
      ],
      "name": "Jean Claude Semuto Ngabonziza"
    },
    {
      "affiliations": [
        "Rwanda Biomedical Center, Kigali, Rwanda",
        "Department of Clinical Biology, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda"
      ],
      "name": "Claude Mambo Muvunyi"
    },
    {
      "affiliations": [
        "School of Chemical Engineering, University of Birmingham, Birmingham, UK",
        "Department of Infectious Diseases & Tropical Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, Birmingham, UK"
      ],
      "name": "Christopher A Green"
    }
  ],
  "title": "Ethnicity and sub-Saharan African representation in the emergency development of covid-19 vaccines",
  "uid": "cafe1d36-252b-51cd-914f-23a1c19cd86b"
}